The ROE as of June 2026 (TTM) for Channel Therapeutics Corporation (CHRO) is -164.11%

According to Channel Therapeutics Corporation’s latest financial reports and current stock price. The company's current ROE is -164.11%. This represents a change of 1.00% compared to the average of -14.91% of the last 4 quarters.

Channel Therapeutics Corporation (CHRO) Historical ROE (quarterly & annually)

How has CHRO ROE performed in the past?

The mean historical ROE of Channel Therapeutics Corporation over the last ten years is 66.20%. The current -164.11% ROE has changed -347.90% with respect to the historical average. Over the past ten years (40 quarters), CHRO's ROE was at its highest in in the June 2024 quarter at 970.64%. The ROE was at its lowest in in the March 2024 quarter at -226.73%.

Channel Therapeutics Corporation (CHRO) ROE by Quarter and Year

Discovering the peaks and valleys of Channel Therapeutics Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Channel Therapeutics Corporation (CHRO) Average ROE

How has CHRO ROE performed in the past?

The current ROE of Channel Therapeutics Corporation (CHRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Channel Therapeutics Corporation (CHRO) ROE vs. Peers

How is CHRO’s ROE compared to its peers?

Channel Therapeutics Corporation’s ROE is greater than Tvardi Therapeutics, Inc. (-64.17%), greater than TNF Pharmaceuticals, Inc. (-59.95%), greater than Omega Therapeutics, Inc. (-118.82%), greater than Turnstone Biologics Corp. (-136.68%), greater than IMV Inc. (-495.17%), greater than CervoMed Inc. (-136.08%), less than Apexigen, Inc. (48.27%), greater than COSCIENS Biopharma Inc. (-13.16%), less than Biora Therapeutics, Inc. (121.86%), greater than ObsEva S.A. (-146.39%),

Build a custom stock screener for Channel Therapeutics Corporation (CHRO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Channel Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Channel Therapeutics Corporation (CHRO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Channel Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.